Last 12 months
Inside the activity.
0 purchase rows · 50 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 23 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2022 Filed Mar 31, 2022 16:31 UTC |
Roberts William T.Chief Accounting Officer
|
SaleCommon Stock | 1,023 | $11.13 | $11,385.99 |
DisclosureSEC source: 0001104659-22-041079 · tm2211062-1_4seq1.xml · nonDerivative · entry 2 Roberts William T. · CIK 0001852360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,477 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 16:31 UTC |
Roberts William T.Chief Accounting Officer
|
Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-041079 · tm2211062-1_4seq1.xml · nonDerivative · entry 1 Roberts William T. · CIK 0001852360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 00:28 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
SaleCommon Stock | 722 | $6.10 | $4,404.20 |
DisclosureSEC source: 0001104659-22-023948 · tm226880-1_4seq1.xml · nonDerivative · entry 2 Chien Jennifer · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 00:31 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 833 | $6.10 | $5,081.30 |
DisclosureSEC source: 0001104659-22-023951 · tm226880-3_4seq1.xml · nonDerivative · entry 2 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,161 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 00:32 UTC |
Shulman JosephChief Technical Officer
|
SaleCommon Stock | 557 | $6.10 | $3,397.70 |
DisclosureSEC source: 0001104659-22-023952 · tm226880d4_4seq1.xml · nonDerivative · entry 2 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,006 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 00:29 UTC |
Mazabraud YannEVP, Head of International
|
SaleCommon Stock | 934 | $6.10 | $5,697.40 |
DisclosureSEC source: 0001104659-22-023949 · tm226880-2_4seq1.xml · nonDerivative · entry 2 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:28 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
Exercise / conversionRestricted Stock Units · Derivative | 2,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023948 · tm226880-1_4seq1.xml · derivative · entry 3 Chien Jennifer · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,093 Underlying: Common Stock · 2,032 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:28 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
Exercise / conversionCommon Stock | 2,032 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-023948 · tm226880-1_4seq1.xml · nonDerivative · entry 1 Chien Jennifer · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:31 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023951 · tm226880-3_4seq1.xml · derivative · entry 3 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,031 Underlying: Common Stock · 2,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:31 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionCommon Stock | 2,344 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-023951 · tm226880-3_4seq1.xml · nonDerivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:32 UTC |
Shulman JosephChief Technical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023952 · tm226880d4_4seq1.xml · derivative · entry 3 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,687 Underlying: Common Stock · 1,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:32 UTC |
Shulman JosephChief Technical Officer
|
Exercise / conversionCommon Stock | 1,563 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-023952 · tm226880d4_4seq1.xml · nonDerivative · entry 1 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:29 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionRestricted Stock Units · Derivative | 2,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023949 · tm226880-2_4seq1.xml · derivative · entry 3 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,093 Underlying: Common Stock · 2,032 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 00:29 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionCommon Stock | 2,032 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-023949 · tm226880-2_4seq1.xml · nonDerivative · entry 1 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:34 UTC |
Manning Linda ShapiroChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-020894 · tm226394-5_4seq1.xml · derivative · entry 2 Manning Linda Shapiro · CIK 0001883256 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:34 UTC |
Manning Linda ShapiroChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-22-020894 · tm226394-5_4seq1.xml · derivative · entry 1 Manning Linda Shapiro · CIK 0001883256 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-08 F1 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:32 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-020889 · tm226394-2_4seq1.xml · derivative · entry 2 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 9,375 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:32 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 56,250 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-22-020889 · tm226394-2_4seq1.xml · derivative · entry 1 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 56,250 shares Expires 2032-02-08 F1 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:35 UTC |
Roberts William T.Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 9,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-020898 · tm226394-9_4seq1.xml · derivative · entry 2 Roberts William T. · CIK 0001852360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,250 Underlying: Common Stock · 9,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:35 UTC |
Roberts William T.Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-22-020898 · tm226394-9_4seq1.xml · derivative · entry 1 Roberts William T. · CIK 0001852360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2032-02-08 F1 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:31 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantStock Option (Right to Buy) · Derivative | 82,500 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-22-020887 · tm226394-1_4seq1.xml · derivative · entry 2 Chien Jennifer · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 82,500 shares Expires 2032-02-08 F3 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:31 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantRestricted Stock Units · Derivative | 13,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-020887 · tm226394-1_4seq1.xml · derivative · entry 1 Chien Jennifer · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:33 UTC |
Meeker David PDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 510,000 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-22-020892 · tm226394-4_4seq1.xml · derivative · entry 1 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,000 Underlying: Common Stock · 510,000 shares Expires 2032-02-08 F1 · derivative.exercise_date: The stock options were granted on February 9, 2022. The option vests and becomes exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:35 UTC |
Smith Hunter CChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 97,500 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-22-020896 · tm226394-7_4seq1.xml · derivative · entry 2 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,500 Underlying: Common Stock · 97,500 shares Expires 2032-02-08 F3 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:35 UTC |
Smith Hunter CChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-020896 · tm226394-7_4seq1.xml · derivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,250 Underlying: Common Stock · 16,250 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:34 UTC |
Shulman JosephChief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 63,750 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-22-020895 · tm226394-6_4seq1.xml · derivative · entry 2 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,750 Underlying: Common Stock · 63,750 shares Expires 2032-02-08 F3 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:34 UTC |
Shulman JosephChief Technical Officer
|
GrantRestricted Stock Units · Derivative | 10,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-020895 · tm226394-6_4seq1.xml · derivative · entry 1 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 Underlying: Common Stock · 10,625 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:33 UTC |
Mazabraud YannEVP, Head of International
|
GrantStock Option (Right to Buy) · Derivative | 82,500 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-22-020890 · tm226394-3_4seq1.xml · derivative · entry 2 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 82,500 shares Expires 2032-02-08 F3 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 09, 2022 Filed Feb 12, 2022 02:33 UTC |
Mazabraud YannEVP, Head of International
|
GrantRestricted Stock Units · Derivative | 13,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-020890 · tm226394-3_4seq1.xml · derivative · entry 1 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 18:51 UTC |
Manning Linda ShapiroChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-116017 · tm2127623-2_4seq1.xml · derivative · entry 2 Manning Linda Shapiro · CIK 0001883256 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of September 10, 2022, September 10, 2023, September 10, 2024 and September 10, 2025. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of September 10, 2022, September 10, 2023, September 10, 2024 and September 10, 2025. The restricted stock units have no expiration date. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 18:51 UTC |
Manning Linda ShapiroChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-21-116017 · tm2127623-2_4seq1.xml · derivative · entry 1 Manning Linda Shapiro · CIK 0001883256 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-09-09 F1 · derivative.exercise_date: The stock options were granted on September 10, 2021. 25% of the shares subject to the option will vest and become exercisable on September 10, 2022 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 00:12 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-096480 · tm2123454-2_4seq1.xml · derivative · entry 2 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 00:12 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $19.02 | $0.00 |
DisclosureSEC source: 0001104659-21-096480 · tm2123454-2_4seq1.xml · derivative · entry 1 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-07-25 F1 · derivative.exercise_date: The stock options were granted on July 26, 2021. 25% of the shares subject to the option will vest and become exercisable on July 26, 2022 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:06 UTC |
GOOD JENNIFER LDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001104659-21-080103 · tm2119501-3_4seq1.xml · derivative · entry 1 GOOD JENNIFER L · CIK 0001229245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-08 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:06 UTC |
MCGIRR DAVID W JDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001104659-21-080107 · tm2119501-5_4seq1.xml · derivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-08 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:05 UTC |
Bedrosian Camille LDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001104659-21-080099 · tm2119501-2_4seq1.xml · derivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-08 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:39 UTC |
Mathers Edward TDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001209191-21-039958 · doc4.xml · derivative · entry 1 Mathers Edward T · CIK 0001328625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-08 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:06 UTC |
JEAN CHRISTOPHEDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001104659-21-080106 · tm2119501-4_4seq1.xml · derivative · entry 1 JEAN CHRISTOPHE · CIK 0001378435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-08 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:06 UTC |
Arbuckle Stuart ADirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001104659-21-080098 · tm2119501-1_4seq1.xml · derivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-08 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:06 UTC |
TETRAULT LYNN A.Director
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001104659-21-080109 · tm2119501-6_4seq1.xml · derivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-08 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders. Read SEC document |
| June 09, 2021 Filed Jun 16, 2021 20:16 UTC Amendment |
Mathers Edward TDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001209191-21-040902 · doc4a.xml · derivative · entry 1 Mathers Edward T · CIK 0001328625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-08 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 10:08 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.88 | $0.00 |
DisclosureSEC source: 0001104659-21-054045 · tm2113817-1_4seq1.xml · derivative · entry 2 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,094 Underlying: Common Stock · 5,000 shares Expires 2027-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted on August 9, 2017. 25% of the stock options vested and became exercisable on July 31, 2018. 75% of the stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 31, 2018. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 10:08 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $6.88 | $34,400.00 |
DisclosureSEC source: 0001104659-21-054045 · tm2113817-1_4seq1.xml · nonDerivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 20:08 UTC |
Meeker David PDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $20.17 | $201,713.00 |
DisclosureSEC source: 0001104659-21-044745 · tm2111512-1_4seq1.xml · nonDerivative · entry 1 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,335 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.03 to $20.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 16:49 UTC |
Roberts William T.Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-043951 · tm2111372-1_4seq1.xml · derivative · entry 2 Roberts William T. · CIK 0001852360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of March 29, 2022, March 29, 2023, March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of March 29, 2022, March 29, 2023, March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 16:49 UTC |
Roberts William T.Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $20.25 | $0.00 |
DisclosureSEC source: 0001104659-21-043951 · tm2111372-1_4seq1.xml · derivative · entry 1 Roberts William T. · CIK 0001852360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-03-28 F1 · derivative.exercise_date: The stock options were granted on March 29, 2021. 25% of the shares subject to the option will vest and become exercisable on March 29, 2022 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 21:13 UTC |
Foley ToddDirector
|
SaleCommon Stock | 1,000,000 | $25.10 | $25,100,000.00 |
DisclosureSEC source: 0001209191-21-020931 · doc4.xml · nonDerivative · entry 1 Foley Todd · CIK 0001473930 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 909,258 F1 · shares: The shares were sold as follows: 962,604 by MPM BioVentures V, L.P. ("BV V") and 37,396 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. The Reporting Person is a member of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. F2 · ownership.nature: Shares are held as follows: 875,256 by BV V and 34,002 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:29 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantStock Option (Right to Buy) · Derivative | 48,750 | $0.00 Strike: $30.66 | $0.00 |
DisclosureSEC source: 0001104659-21-024421 · tm216849-6_4seq1.xml · derivative · entry 2 Chien Jennifer · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,750 Underlying: Common Stock · 48,750 shares Expires 2031-02-10 F3 · derivative.exercise_date: The stock options were granted on February 11, 2021. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:29 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantRestricted Stock Units · Derivative | 8,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-024421 · tm216849-6_4seq1.xml · derivative · entry 1 Chien Jennifer · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,125 Underlying: Common Stock · 8,125 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:26 UTC |
Meeker David PDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 220,000 | $0.00 Strike: $30.66 | $0.00 |
DisclosureSEC source: 0001104659-21-024406 · tm216849-1_4seq1.xml · derivative · entry 1 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2031-02-10 F1 · derivative.exercise_date: The stock options were granted on February 11, 2021. The option vests and becomes exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.